Yew Chung Tang

MiRXES Welcomes Genomics Expert to Scientific Advisory Board

Press Release MiRXES Welcomes Genomics Expert to Scientific Advisory Board Dr Holger Heyn, an expert in single-cell genomics and spatial transcriptomics, has joined the Scientific Advisory Board of MiRXES to help advance its development of RNA-powered multi-omics solutions for research and diagnostics.    Dr Holger Heyn, MiRXES Scientific Advisory Board member SINGAPORE, 28 July 2021 …

MiRXES Welcomes Genomics Expert to Scientific Advisory Board Read More »

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support

Press Release MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare MiRXES team in action SINGAPORE, 8 July 2021 – MiRXES Pte …

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support Read More »

Leveling up with MiRXES

Insights Leveling up with MiRXES MiRXES is on the lookout for talents who can contribute to its mission against diseases like cancer through leading-edge diagnostic tools. MiRXES team in action As the saying goes, the early bird catches the worm—and nowhere is this truer than in the world of healthcare. Each year, over a million …

Leveling up with MiRXES Read More »

MiRXES TeamTalk: Jeremiah Decosta

Insights TeamTalk: Jeremiah Decosta As Vice President for Manufacturing and Regulatory Affairs at MiRXES, Jeremiah Decosta harnesses smart technologies to accelerate processes in the plants while ensuring quality diagnostics. Jeremiah Decosta, VP for Manufacturing & Regulatory Affairs at MiRXES. In the world of medical diagnostics manufacturing, there’s no room for error. Even the smallest slip-up …

MiRXES TeamTalk: Jeremiah Decosta Read More »

Meeting the microRNA Profiling Challenge

Insights Meeting the microRNA Profiling Challenge Compared to other commercial microRNA profiling platforms, MiRXES’s ID3EAL qPCR platform stands out when used to discover and validate blood-based miRNA biomarkers. From painful biopsies to invasive procedures, certain diagnostic exams have gotten a bad rap over the years for the discomfort they tend to cause. The 2008 discovery …

Meeting the microRNA Profiling Challenge Read More »

Scroll to Top